GAMMA Investing »

Kailera Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Kailera Therapeutics (KLRA) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2026-09-30 $388 34 11.41

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Micron Technology Common Stock (MU)
Eli Lilly Common Stock (LLY)
Advanced Micro Devices Common Stock (AMD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Tesla Common Stock (TSLA)

View all positions for GAMMA Investing

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics